Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Matsons
MATX
$6.39B
| $7.04M | ﹤0.01% |
56,946
+5,847
| +11% | +$628K |
|
1952
SoundHound AI
SOUN
$3.32B
| $7.03M | ﹤0.01% |
705,325
+133,957
| +23% | +$1.93M |
|
1953
Lattice Semiconductor
LSCC
$18.2B
| $7.02M | ﹤0.01% |
95,451
-49,528
| -34% | -$3.53M |
|
1954
CALL
SLB Ltd
SLB
$77.3B
| $7.02M | ﹤0.01% |
182,800
| – | – |
|
1955
Shift4
FOUR
$3.79B
| $7M | ﹤0.01% |
111,102
+47,535
| +75% | +$3.36M |
|
1956
Ring Energy
REI
$349M
| $6.96M | ﹤0.01% |
8,000,001
-89
| -0% | -$85 |
|
1957
Globus Medical
GMED
$11.5B
| $6.95M | ﹤0.01% |
79,592
-134,439
| -63% | -$10.2M |
|
1958
Fulton Financial
FULT
$4.69B
| $6.95M | ﹤0.01% |
359,307
+67,499
| +23% | +$1.24M |
|
1959
PUT
Applovin
APP
$105B
| $6.94M | ﹤0.01% |
10,300
-10,100
| -50% | -$6.36M |
|
1960
AppFolio
APPF
$7.22B
| $6.94M | ﹤0.01% |
29,821
+8,207
| +38% | +$1.95M |
|
1961
InvenTrust Properties
IVT
$2.62B
| $6.93M | ﹤0.01% |
245,599
+10,999
| +5% | +$310K |
|
1962
PUT
Cloudflare
NET
$118B
| $6.92M | ﹤0.01% |
35,100
| – | – |
|
|
TERN
1963
DELISTED
Terns Pharmaceuticals
TERN
| $6.92M | ﹤0.01% |
171,186
+40,795
| +31% | +$943K |
|
1964
Thor Industries
THO
$4.11B
| $6.91M | ﹤0.01% |
67,346
+17,264
| +34% | +$1.79M |
|
1965
Global Net Lease
GNL
$1.9B
| $6.91M | ﹤0.01% |
803,995
-349,895
| -30% | -$2.8M |
|
1966
CALL
uniQure
QURE
$3.26B
| $6.88M | ﹤0.01% |
287,500
+194,300
| +208% | +$7.5M |
|
1967
Franklin Electric
FELE
$4.68B
| $6.87M | ﹤0.01% |
71,878
+3,082
| +4% | +$294K |
|
1968
Valaris
VAL
$5.91B
| $6.86M | ﹤0.01% |
136,169
-11,495
| -8% | -$617K |
|
1969
FormFactor
FORM
$10.3B
| $6.85M | ﹤0.01% |
122,738
+12,289
| +11% | +$619K |
|
1970
Planet Fitness
PLNT
$3.71B
| $6.84M | ﹤0.01% |
63,060
-22,854
| -27% | -$2.35M |
|
1971
Patterson-UTI
PTEN
$4.16B
| $6.83M | ﹤0.01% |
1,118,490
-466,954
| -29% | -$2.79M |
|
1972
Independent Bank
INDB
$4.05B
| $6.83M | ﹤0.01% |
93,504
+20,614
| +28% | +$1.46M |
|
1973
Argan
AGX
$7.84B
| $6.78M | ﹤0.01% |
21,637
+1,861
| +9% | +$591K |
|
1974
First Interstate BancSystem
FIBK
$3.7B
| $6.77M | ﹤0.01% |
195,766
+34,328
| +21% | +$1.12M |
|
|
TPC
1975
Tutor Perini Cor
TPC
$4.98B
| $6.77M | ﹤0.01% |
100,995
+7,319
| +8% | +$480K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.